You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

Abametapir - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for abametapir and what is the scope of patent protection?

Abametapir is the generic ingredient in one branded drug marketed by Hatchtech and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Abametapir has thirty-five patent family members in fifteen countries.

One supplier is listed for this compound.

Summary for abametapir
International Patents:35
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 112
Clinical Trials: 6
Patent Applications: 489
What excipients (inactive ingredients) are in abametapir?abametapir excipients list
DailyMed Link:abametapir at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for abametapir
Generic Entry Date for abametapir*:
Constraining patent/regulatory exclusivity:
Dosage:
LOTION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for abametapir

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hatchtech Pty LtdPhase 2
Dr. Reddy's Laboratories LimitedPhase 2
INC ResearchPhase 3

See all abametapir clinical trials

US Patents and Regulatory Information for abametapir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for abametapir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 ⤷  Sign Up ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 ⤷  Sign Up ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for abametapir

Country Patent Number Title Estimated Expiration
Canada 2595468 PROCEDES ET COMPOSITIONS SERVANT A LUTTER CONTRE DES ECTOPARASITES (METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES) ⤷  Sign Up
China 100593419 ⤷  Sign Up
Australia 2004257351 Methods and compositions for controlling ectoparasites ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2006076761 ⤷  Sign Up
Eurasian Patent Organization 201691033 ПЕДИКУЛИЦИДНАЯ КОМПОЗИЦИЯ ⤷  Sign Up
European Patent Office 3082424 COMPOSITION PEDICULICIDE (PEDICULICIDAL COMPOSITION) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.